We are live on ! Find out more
IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+17.25%
3 Year Est. Return
+11.14%
5 Year Est. Return
+79.35%
10 Year Est. Return
–
AUM
$260M
AUM Growth
+$4.09M
Cap. Flow
-$10.4M
Cap. Flow %
-3.98%
Top 10 Hldgs %
46.09%
Holding
68
New
5
Increased
11
Reduced
10
Closed
14

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$11.8M
2
SPPI
Spectrum Pharmaceuticals Inc
SPPI
+$5.56M
3
ABMD
Abiomed Inc
ABMD
+$4.78M
4
INCY icon
Incyte
INCY
+$3.62M
5
XENT
Intersect ENT, Inc
XENT
+$2.94M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$11.9M
2
SAGE
Sage Therapeutics
SAGE
+$4.32M
3
CLVS
Clovis Oncology, Inc.
CLVS
+$4.01M
4
GILD icon
Gilead Sciences
GILD
+$2.9M
5
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
+$2.73M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FSTX
51
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$860K 0.33%
18,250
– –
VKTX icon
52
Viking Therapeutics
VKTX
$3.95B
$664K 0.26%
70,000
– –
RDUS
53
DELISTED
Radius Health, Inc.
RDUS
$554K 0.21%
18,799
– –
RSLS
54
DELISTED
ReShape Lifesciences Inc. Common Stock
RSLS
$121K 0.05%
375
– –
ACAD icon
55
Acadia Pharmaceuticals
ACAD
$5.12B
– –
-42,773
Closed -$961K
ANAB icon
56
AnaptysBio
ANAB
$1.7B
– –
-8,500
Closed -$885K
AXGN icon
57
Axogen
AXGN
$2.78B
– –
-50,000
Closed -$1.82M
ESPR
58
DELISTED
Esperion Therapeutics
ESPR
– –
-10,000
Closed -$723K
OPTN
59
DELISTED
OptiNose
OPTN
– –
-4,333
Closed -$1.3M
PEN icon
60
Penumbra
PEN
$12.6B
– –
-14,000
Closed -$1.62M
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$2.59B
– –
-41,000
Closed -$2.09M
ONC
62
BeOne Medicines Ltd
ONC
$42.1B
– –
-9,500
Closed -$1.6M
MTEM
63
DELISTED
Molecular Templates, Inc.
MTEM
– –
-16,506
Closed -$1.98M
CLVS
64
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-76,000
Closed -$4.01M
FOMX
65
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-63,202
Closed -$324K
SGYP
66
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-1,505,809
Closed -$2.73M
TSRO
67
DELISTED
TESARO, Inc.
TSRO
– –
-21,300
Closed -$1.22M
AVXS
68
DELISTED
AveXis, Inc. Common Stock
AVXS
– –
-17,000
Closed -$2.1M
1 2
3

Similar funds

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
DT
Daniels + Tansey Wilmington, Delaware $289M AUM 18.06% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
TFA
Triad Financial Advisors Greensboro, North Carolina $284M AUM 14.95% 1-Year Est. Return
SFG
Steward Financial Group Colleyville, Texas $315M AUM 13.78% 1-Year Est. Return
AEPLI
AH Equity Partners LSV I Menlo Park, California $315M AUM 9.31% 1-Year Est. Return
CC
Chanos & Company New York $318M AUM 4.62% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

International Biotechnology Trust's Q2 2018 Portfolio in Review

As of Q2 2018, International Biotechnology Trust held 68 positions worth $260M, up 1.6% from $256M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

International Biotechnology Trust withdrew a net $10.4M in Q2 2018, closing 14 positions and reducing 10 holdings. Its most notable exit was Clovis Oncology, Inc., an estimated $4.01M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, International Biotechnology Trust opened a new position in Illumina worth $12.6M.

  • International Biotechnology Trust's largest Q2 2018 buy was Illumina: 46,260 shares worth $12.6M.
  • International Biotechnology Trust added most to Incyte in Q2 2018, an estimated $3.62M increase.
  • International Biotechnology Trust's biggest Q2 2018 reduction was Shire pic, cutting an estimated $11.9M.
  • International Biotechnology Trust fully exited Clovis Oncology, Inc. in Q2 2018, selling an estimated $4.01M.
  • International Biotechnology Trust's ten largest holdings make up 46% of its $260M portfolio in Q2 2018.
  • International Biotechnology Trust opened 5 new positions and closed 14 in Q2 2018.
  • International Biotechnology Trust's portfolio value rose 1.6% quarter-over-quarter to $260M.

Based on International Biotechnology Trust's 13F filing for Q2 2018, filed 13 Aug 2018.